Need Help?
Copied to clipboard!

High prevalence of CHIP after 177Lu-DOTA-TATE

In Neuroendocrine tumors (NETs), 177Lu-DOTA-TATE peptide receptor radionuclide therapy (PRRT) has demonstrated efficacy but significant hematologic toxicity, including therapy-related myeloid neoplasms (t-MN). Here, we assessed the prevalence of clonal hematopoiesis (CHIP), a known risk factor for therapy-related myeloid neoplasms (t-MN), according to previous PRRT exposure.

Cite

Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data

Dataset ID Description Technology Samples
EGAD50000003135 Illumina MiSeq NextSeq 500 NextSeq 550 152